T1	Treatment 14 32	placebo-controlled
T2	Treatment 60 94	recombinant hypoallergenic Bet v 1
T3	Treatment 302 335	recombinant Bet v 1 (rBet v 1-FV)
T4	Treatment 466 496	environmental exposure chamber
T5	Treatment 624 638	of rBet v 1-FV
T6	Treatment 643 654	one placebo
T7	Treatment 728 739	and placebo
T8	Treatment 1093 1105	with placebo
T9	Treatment 1625 1642	of 80 Î¼g of rBet
